|

INDUSTRY

Stemcells, Inc. to Aquire Cell-based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences plc for US$4.8 Million Stem Cell Sciences plc recently announced that it has entered into a definitive agreement with StemCells, Inc. for the sale of the Trading Subsidiaries of the Company and certain ancillary agreements, assets, properties and rights for a maximum total consideration of approximately US$4,849,000.
The California Institute for Regenerative Medicine Completes Briefing Visit to Stemedica Cell Technologies Stemedica Cell Technologies is seeking approval from the California Department of Health to begin the production of adult stem cells for Phase I and II clinical trials at its facility in San Diego, US.
Profs Weigh Leaving Harvard over Allston Slowdown The University's plan to deal with the slowdown by re-assigning cellular biology laboratory space to stem cell researchers has raised concerns that basic biology research is being de-prioritized in the current financial crisis, according to several professors.
Stem Cell Patents-Reexamination/Litigation-The Last 5 Years Many patents relating to stem cell technology have faced reexamination, litigation, or both in the last five years.
|
|
POLICY
Obama to Sign Stem Cells Order on Monday
President Barack Obama, who opposes limits on federal funding of stem cell research, will sign an executive order about stem cells on Monday, an administration official said on Friday.
Obama Is Leaving Some Stem Cell Issues to Congress
The officials, who provided details of the announcement Mr. Obama will make Monday at the White House, said the president would leave it to Congress to determine whether the long-standing legislative ban on federal financing for human embryo experiments should also be overturned.
Biotech Impact from Obama Plan Muted
Most of President Barack Obama's budget will have little impact on large biotechnology companies, according to a Citi analyst, though several will have to prepare for potential competition from copies of their treatments.
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|